Literature DB >> 25208653

Expression of the Mas receptor is upregulated in skeletal muscle wasting.

María Gabriela Morales1, Johanna Abrigo, Carla Meneses, Franco Cisternas, Felipe Simon, Claudio Cabello-Verrugio.   

Abstract

Skeletal muscle atrophy during sepsis, immobilization, and chronic diseases is characterized by an increase in expression and activity of the muscle-specific ubiquitin 3 ligases atrogin-1 and MuRF-1. The classical renin-angiotensin system (RAS), by high level of circulating angiotensin II (AngII) is directly involved in skeletal muscle wasting associated with cardiac and renal failure. Ang (1-7), a peptide belonging to the non-classical RAS system, produces effects that are opposite to AngII. The actions of Ang (1-7) are mediated by its binding and signalling through the Mas receptor. Our purpose is to assess the effects of atrophic stimuli AngII, lipopolysaccharide (LPS), and immobilization on the expression of the Mas receptor in skeletal muscle. For that we used gastrocnemius and tibialis anterior muscles of C57BL10 mice treated with AngII, LPS or subjected to unilateral hindlimb immobilization by casting. In addition, we used C2C12 myotubes incubated with AngII or LPS. We evaluated Mas expression by quantitative real-time PCR, Western blot immunohistochemical analysis. Skeletal muscle atrophy was corroborated by the expression of atrogin-1 and MuRF-1 and the fibre diameter. Our results show that Mas receptor expression was increased by AngII or LPS in vitro and in vivo, and upregulated by immobilization. The increase of the Mas expression was concomitantly with the upregulation of atrogin-1 and MuRF-1 and the reduction of the fibre diameter. These results from studies in vitro and in vivo demonstrate for the first time that the Mas receptor is increased under atrophic stimulus and suggest that the non-classical RAS system could have an important role in muscle wasting.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25208653     DOI: 10.1007/s00418-014-1275-1

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  80 in total

1.  Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects.

Authors:  Michikado Iwata; Randy T Cowling; Devorah Gurantz; Cristina Moore; Shen Zhang; Jason X-J Yuan; Barry H Greenberg
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-15       Impact factor: 4.733

2.  Suppressing inflammation by inhibiting the NF-κB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia.

Authors:  Teng Jiang; Li Gao; Jun Guo; Jie Lu; Yao Wang; Yingdong Zhang
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

Review 3.  Skeletal muscle hypertrophy and atrophy signaling pathways.

Authors:  David J Glass
Journal:  Int J Biochem Cell Biol       Date:  2005-10       Impact factor: 5.085

Review 4.  Angiotensin II, oxidative stress and skeletal muscle wasting.

Authors:  Sergiy Sukhanov; Laura Semprun-Prieto; Tadashi Yoshida; A Michael Tabony; Yusuke Higashi; Sarah Galvez; Patrice Delafontaine
Journal:  Am J Med Sci       Date:  2011-08       Impact factor: 2.378

Review 5.  The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy.

Authors:  Victoria C Foletta; Lloyd J White; Amy E Larsen; Bertrand Léger; Aaron P Russell
Journal:  Pflugers Arch       Date:  2011-01-11       Impact factor: 3.657

Review 6.  Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II.

Authors:  Rajiv Agarwal; Ruth C Campbell; David G Warnock
Journal:  Semin Nephrol       Date:  2004-03       Impact factor: 5.299

7.  Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues.

Authors:  R Metzger; M Bader; T Ludwig; C Berberich; B Bunnemann; D Ganten
Journal:  FEBS Lett       Date:  1995-01-02       Impact factor: 4.124

8.  Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles.

Authors:  Claudio Cabello-Verrugio; María Gabriela Morales; Daniel Cabrera; Carlos P Vio; Enrique Brandan
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

Review 9.  Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.

Authors:  John S Lubel; Chandana B Herath; Louise M Burrell; Peter W Angus
Journal:  J Gastroenterol Hepatol       Date:  2008-06-28       Impact factor: 4.029

Review 10.  Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis.

Authors:  Masaru Iwai; Masatsugu Horiuchi
Journal:  Hypertens Res       Date:  2009-05-22       Impact factor: 3.872

View more
  15 in total

Review 1.  The Histochemistry and Cell Biology omnium-gatherum: the year 2015 in review.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2016-02-15       Impact factor: 4.304

Review 2.  Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.

Authors:  Sadashiva S Karnik; Khuraijam Dhanachandra Singh; Kalyan Tirupula; Hamiyet Unal
Journal:  Br J Pharmacol       Date:  2017-03-09       Impact factor: 8.739

3.  Effects of ACE2 deficiency on physical performance and physiological adaptations of cardiac and skeletal muscle to exercise.

Authors:  Daisy Motta-Santos; Robson Augusto Souza Dos Santos; Marilene Oliveira; Fatimunnisa Qadri; Marko Poglitsch; Valentina Mosienko; Lenice Kappes Becker; Maria Jose Campagnole-Santos; Joseph M Penninger; Natalia Alenina; Michael Bader
Journal:  Hypertens Res       Date:  2016-04-07       Impact factor: 3.872

4.  ACE Inhibitors and Sarcopenia: Covering All the BASEs?

Authors:  Jochen Springer; Stephan von Haehling
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

5.  Different effects of the deletion of angiotensin converting enzyme 2 and chronic activation of the renin-angiotensin system on muscle weakness in middle-aged mice.

Authors:  Hikari Takeshita; Koichi Yamamoto; Masaki Mogi; Satoko Nozato; Masatsugu Horiuchi; Hiromi Rakugi
Journal:  Hypertens Res       Date:  2019-12-19       Impact factor: 3.872

Review 6.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

7.  Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas.

Authors:  María Gabriela Morales; Johanna Abrigo; María José Acuña; Robson A Santos; Michael Bader; Enrique Brandan; Felipe Simon; Hugo Olguin; Daniel Cabrera; Claudio Cabello-Verrugio
Journal:  Dis Model Mech       Date:  2016-02-05       Impact factor: 5.758

8.  Age-related changes in vascular responses to angiotensin-(1-7) in female mice.

Authors:  Fabiana P Costa-Fraga; Gleisy K Goncalves; Fernando P Souza-Neto; Adelina M Reis; Luciano As Capettini; Robson As Santos; Rodrigo A Fraga-Silva; Nikolaos Stergiopulos; Rafaela F da Silva
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Jul-Sep       Impact factor: 1.636

9.  High Fat Diet-Induced Skeletal Muscle Wasting Is Decreased by Mesenchymal Stem Cells Administration: Implications on Oxidative Stress, Ubiquitin Proteasome Pathway Activation, and Myonuclear Apoptosis.

Authors:  Johanna Abrigo; Juan Carlos Rivera; Javier Aravena; Daniel Cabrera; Felipe Simon; Fernando Ezquer; Marcelo Ezquer; Claudio Cabello-Verrugio
Journal:  Oxid Med Cell Longev       Date:  2016-08-08       Impact factor: 6.543

10.  COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.

Authors:  Geoffroy Méry; Olivier Epaulard; Anne-Laure Borel; Bertrand Toussaint; Audrey Le Gouellec
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.